- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT01567917
Incidence of Venous Thromboembolism Following Surgery in Patients With Colorectal Cancer
Incidence of Venous Thromboembolism Following Surgery in Korean Patients With Colorectal Cancer; a Prospective Study
Venous thromboembolism (VTE) has harmful effects on morbidity and mortality of cancer patients. In Western VTE guidelines, all solid cancer patients receiving abdominal major surgery are strongly recommended to receive pharmacologic prophylactic anticoagulation such as low molecular weight heparin (LMWH) in the perioperative periods. These recommendations are based on the high incidence of postoperative VTE development in Western cancer patients. However, there have been many cumulative data about the effect of different ethnicity on the VTE development and more and more investigators and clinicians admit that Asian ethnicity has lower incidence of VTE than Western ethnicity. Therefore, it may not be advisable to apply Western guidelines as it is to the clinical situation of Asian cancer patients.
Although colorectal cancer (CRC) is one of the common cancers and the incidence is rapidly increasing in Asia, there have been few prospective data on the incidence of VTE development during the postoperative period in Asian CRC patients. To our knowledge, there have been a few small-sized prospective studies in Asia and thus clear conclusions could have not been drawn based on those studies. Most Korean colorectal surgeons think that the incidence of postoperative VTE development is very rare based on their own clinical experiences. They also have much concern about the complications such as bleeding that might be caused by routine use of pharmacologic thromboprophylaxis during the perioperative periods. Therefore, in most clinical situation, many Korean colorectal surgeons do not perform perioperative pharmacologic thromboprophylaxis using LMHW. Considering these clinical situations in Asia including Korea, the uncritical acceptance of Western guidelines may be inappropriate. The necessity of pharmacologic thrombo-prophylaxis can be answered only from our own prospective study on the incidence of postoperative VTE development after CRC surgery. Moreover, current surgical trend in cancer patients is minimally invasive approach such as laparoscopic surgery. However, the necessity of pharmacologic thromboprophylaxis in patients receiving laparoscopic cancer surgery has not been evaluated even in Western countries. Western guidelines also cannot exactly answer whether pharmacologic thromboprophylaxis is really necessary in cancer patients receiving laparoscopic cancer surgery. On above backgrounds, this study was designed.
Panoramica dello studio
Stato
Intervento / Trattamento
Tipo di studio
Iscrizione (Anticipato)
Contatti e Sedi
Contatto studio
- Nome: Keun-Wook Lee, M.D. & Ph.D.
- Numero di telefono: 82-31-787-7009
- Email: hmodoctor@hanmail.net
Luoghi di studio
-
-
Gyeonggi-do
-
Seongnam, Gyeonggi-do, Corea, Repubblica di, 463-707
- Reclutamento
- Seoul National University Bundang Hospital
-
Contatto:
- Keun-Wook Lee, M.D.. & Ph.D.
- Numero di telefono: 82-31-787-7009
- Email: hmodoctor@hanmail.net
-
Sub-investigatore:
- Jee Hyun Kim, M.D. & Ph.D.
-
Sub-investigatore:
- Sung-Bum Kang, M.D. & Ph.D.
-
Sub-investigatore:
- Duck-Woo Kim, M.D. & Ph.D.
-
Sub-investigatore:
- Jin Won Kim, M.D.
-
Sub-investigatore:
- Sang Il Choi, M.D. & Ph.D.
-
Sub-investigatore:
- Eun Ju Chun, M.D. & Ph.D.
-
Sub-investigatore:
- Soo Mee Bang, M.D. & Ph.D.
-
Sub-investigatore:
- Jeong-Ok Lee, M.D.
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
- Histologically confirmed adenocarcinoma of colon or rectum
- Age ≥ 20 years
- Patients receiving curative or palliative abdominal surgery (lasting ≥ 30 minutes) (both open and laparoscopic surgery will be included)
Exclusion Criteria:
- No histological confirmation
- Patients who already have VTE (or pulmonary embolism) at the screening periods of this study
- Past medical history of VTE or pulmonary embolism
- Patients with the history of other cancer (Patients who were disease-free for > 5 years from previous other cancer is allowed to be included in this study)
- Patients with thrombophilia or other comorbidities requiring anticoagulation (i.e. atrial fibrillation or cerebral infarct requiring anticoagulation
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Modelli osservazionali: Coorte
- Prospettive temporali: Prospettiva
Coorti e interventi
Gruppo / Coorte |
Intervento / Trattamento |
---|---|
Group A
Patients who gave a permission to this study and underwent doppler US (Doppler US cohort - Expected subject no.: 400 patients |
Patients will receive surgery for the treatment of CRC as routine clinical practice. These patients will be prospectively observed for the development of VTE(Group A; Doppler US cohort vs. Group B; Simple observation cohort) - Doppler US is not an intervention. The Doppler US is a non-invasive test (ultrasonography) for the detection of VTE |
Group B
Patient who gave a permission to this study, but who did not receive doppler US (Although this group of patients did not undergo doppler US, these patients will be included as group B [simple observation cohort without doppler US examination]) - Expected subject no.: 200 patients |
Patients will receive surgery for the treatment of CRC as routine clinical practice. These patients will be prospectively observed for the development of VTE(Group A; Doppler US cohort vs. Group B; Simple observation cohort) - Doppler US is not an intervention. The Doppler US is a non-invasive test (ultrasonography) for the detection of VTE |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
The incidence of symptomatic or asymptomatic VTE
Lasso di tempo: 5~14 days after CRC surgery (by doppler venous ultrasound [US]) or the follow-up period of postoperative 1 month
|
To evaluate the incidence of symptomatic or asymptomatic VTE detected by Doppler US during postoperative periods in patients with CRC receiving surgery
|
5~14 days after CRC surgery (by doppler venous ultrasound [US]) or the follow-up period of postoperative 1 month
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Risk factors for the development of VTE
Lasso di tempo: 5~14 days after CRC surgery (by doppler US) or the follow-up period of postoperative 1 month
|
To identify risk factors for the development of VTE in this population
|
5~14 days after CRC surgery (by doppler US) or the follow-up period of postoperative 1 month
|
Collaboratori e investigatori
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Anticipato)
Completamento dello studio (Anticipato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
- Malattie dell'apparato digerente
- Malattia cardiovascolare
- Malattie vascolari
- Neoplasie
- Neoplasie per sede
- Neoplasie gastrointestinali
- Neoplasie dell'apparato digerente
- Malattie gastrointestinali
- Embolia e Trombosi
- Malattie del colon
- Malattie intestinali
- Neoplasie intestinali
- Malattie del retto
- Neoplasie colorettali
- Tromboembolia
- Tromboembolia venosa
Altri numeri di identificazione dello studio
- CRC-SNUBH-2012-01
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su CRC surgery
-
Yale UniversityNational Cancer Institute (NCI)CompletatoCancro colorettaleStati Uniti
-
University of California, San FranciscoSan Francisco State University; NICOS Chinese Health CoalitionCompletatoNeoplasie colorettaliStati Uniti
-
University Hospital, GhentFlemish institute of biotechnology (VIB)ReclutamentoMetastasi peritonealiBelgio
-
Memorial Sloan Kettering Cancer CenterCANCER PREVENTION FUNDReclutamentoScreening del cancro al colonStati Uniti
-
ARCAGY/ GINECO GROUPReclutamentoCancro ovarico stadio IIIC | Stadio del cancro ovarico IV | Cancro ovarico stadio IIIbFrancia
-
Digital Health Navigation Solutions, IncNational Cancer Institute (NCI); Wake Forest University Health SciencesNon ancora reclutamentoScreening del cancro colorettaleStati Uniti
-
ISA Associates, Inc.ReclutamentoCancro colorettaleStati Uniti
-
Genomictree, Inc.Samsung Medical Center; Pusan National University Hospital; Asan Medical Center; Seoul... e altri collaboratoriReclutamentoCancro colorettale | Neoplasia colorettale avanzata | Adenomi avanzati | Polipi non neoplastici | Adenomi non avanzatiCorea, Repubblica di
-
Mayo ClinicTerminatoReflusso gastroesofageo | Ernia, iatale | Sondaggi e questionari | FundoplicatioStati Uniti
-
Fudan UniversitySconosciuto